DB16373InvestigationalProtein Based Therapies
Melrilimab is under investigation in clinical trial NCT03207243 (Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma).
- Mechanism
- Curator reviewed
Pharmacologically active on Interleukin-33 and Interleukin-1 receptor-like 1
- Code names
- CNTO-7160 · GSK-3772847
Resolves to
Compound
Targets
What you can answer from here — as of July 08, 2026
Which drugs share a target with Melrilimab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account